ID   TAOK2_HUMAN             Reviewed;        1235 AA.
AC   Q9UL54; A5PKY1; A7MCZ2; B2RN35; O94957; Q6UW73; Q7LC09; Q9NSW2;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   05-OCT-2010, entry version 84.
DE   RecName: Full=Serine/threonine-protein kinase TAO2;
DE            EC=2.7.11.1;
DE   AltName: Full=Kinase from chicken homolog C;
DE            Short=hKFC-C;
DE   AltName: Full=Prostate-derived STE20-like kinase 1;
DE            Short=PSK-1;
DE   AltName: Full=Thousand and one amino acid protein 2;
GN   Name=TAOK2; Synonyms=KIAA0881, MAP3K17, PSK, PSK1;
GN   ORFNames=UNQ2971/PRO7431;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND MUTAGENESIS OF LYS-57.
RC   TISSUE=Mammary carcinoma;
RX   MEDLINE=20127920; PubMed=10660600; DOI=10.1074/jbc.275.6.4311;
RA   Moore T.M., Garg R., Johnson C., Coptcoat M.J., Ridley A.J.,
RA   Morris J.D.H.;
RT   "PSK, a novel STE20-like kinase derived from prostatic carcinoma that
RT   activates the JNK MAPK pathway and regulates actin cytoskeletal
RT   organisation.";
RL   J. Biol. Chem. 275:4311-4322(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, SELF-ASSOCIATION,
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=13679851; DOI=10.1038/sj.onc.1206605;
RA   Yustein J.T., Xia L., Kahlenburg J.M., Robinson D., Templeton D.,
RA   Kung H.-J.;
RT   "Comparative studies of a new subfamily of human Ste20-like kinases:
RT   homodimerization, subcellular localization, and selective activation
RT   of MKK3 and p38.";
RL   Oncogene 22:6129-6141(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   MEDLINE=99156230; PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Fetal brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 957-1235 (ISOFORMS 1/3).
RX   MEDLINE=22887296; PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH TUBULINS, AND
RP   MUTAGENESIS OF LYS-57.
RX   PubMed=12639963; DOI=10.1074/jbc.M213064200;
RA   Mitsopoulos C., Zihni C., Garg R., Ridley A.J., Morris J.D.;
RT   "The prostate-derived sterile 20-like kinase (PSK) regulates
RT   microtubule organization and stability.";
RL   J. Biol. Chem. 278:18085-18091(2003).
RN   [10]
RP   FUNCTION, INTERACTION WITH MAP3K7, AND MUTAGENESIS OF LYS-57 AND
RP   ASP-169.
RX   PubMed=16893890; DOI=10.1074/jbc.M603627200;
RA   Huangfu W.C., Omori E., Akira S., Matsumoto K., Ninomiya-Tsuji J.;
RT   "Osmotic stress activates the TAK1-JNK pathway while blocking TAK1-
RT   mediated NF-kappaB activation: TAO2 regulates TAK1 pathways.";
RL   J. Biol. Chem. 281:28802-28810(2006).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-181,
RP   AUTOPHOSPHORYLATION, AND MUTAGENESIS OF LYS-57 AND ASP-919.
RX   PubMed=17158878; DOI=10.1074/jbc.M608336200;
RA   Zihni C., Mitsopoulos C., Tavares I.A., Baum B., Ridley A.J.,
RA   Morris J.D.;
RT   "Prostate-derived sterile 20-like kinase 1-alpha induces apoptosis.
RT   JNK-and caspase-dependent nuclear localization is a requirement for
RT   membrane blebbing.";
RL   J. Biol. Chem. 282:6484-6493(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9; SER-437; SER-486;
RP   SER-777; SER-825 AND SER-827, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9; SER-181; SER-449;
RP   SER-473; SER-486; SER-493 AND SER-827, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-1011 (ISOFORM 2), AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
CC   -!- FUNCTION: Isoform 1, but not isoform 2, plays a role in apoptotic
CC       morphological changes, including cell contraction, membrane
CC       blebbing and apoptotic bodies formation. This function, which
CC       requires the activation of MAPK8/JNK and nuclear localization of
CC       C-terminally truncated isoform 1, may be linked to the
CC       mitochondrial CASP9-associated death pathway. Isoform 1, but not
CC       isoform 2, activates the JNK MAP kinase pathway through the
CC       specific activation of the upstream MKK3 and MKK6 kinases. Isoform
CC       1 binds to microtubules and affects their organization and
CC       stability independently of its kinase activity. Prevents MAP3K7-
CC       mediated activation of IKKA, and thus NF-kappa-B activation, but
CC       not that of JNK. Phosphorylates itself, MBP, activated MAPK8 and
CC       tubulins. May play a role in the osmotic stress-MAPK8 pathway.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium (By similarity).
CC   -!- SUBUNIT: Interacts with MKK3 and MKK6 (By similarity). Self-
CC       associates. Interacts with tubulins through the C-terminal domain.
CC       Interacts with MAP3K7 and interfers with MAP3K7-binding to IKKA
CC       and thus prevents NF-kappa-B activation.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane; Multi-pass
CC       membrane protein (Potential). Cytoplasm, cytoskeleton. Nucleus.
CC       Note=Catalytically active full-length phosphorylated isoform 1
CC       localizes to microtubules in the cytoplasm predominantly on
CC       microtubule cables positioned around the nucleus. A C-terminally
CC       truncated form of isoform 1 is present in the nucleus; isoform 2
CC       and kinase-defective, as well as full-length isoform 1 are
CC       excluded from the nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=PSK1-alpha, TAO2;
CC         IsoId=Q9UL54-1; Sequence=Displayed;
CC       Name=2; Synonyms=PSK1-beta;
CC         IsoId=Q9UL54-2; Sequence=VSP_015969, VSP_015970;
CC         Note=Phosphorylated on Ser-1011;
CC       Name=3;
CC         IsoId=Q9UL54-3; Sequence=VSP_015967, VSP_015968;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, with a higher level of
CC       expression in testis and brain.
CC   -!- PTM: Isoforms 1 and 2 are autophosphorylated.
CC   -!- PTM: C-terminal cleavage of isoform 1 and subsequent nuclear
CC       localization requires CASP9 activity.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAQ89301.1; Type=Erroneous initiation; Note=Translation N-terminally extended;
CC       Sequence=BAA74904.2; Type=Erroneous initiation; Note=Translation N-terminally shortened;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF061943; AAD45616.1; -; mRNA.
DR   EMBL; AF263313; AAG38503.1; -; mRNA.
DR   EMBL; AB020688; BAA74904.2; ALT_INIT; mRNA.
DR   EMBL; AK291473; BAF84162.1; -; mRNA.
DR   EMBL; AL137701; CAB70882.1; -; mRNA.
DR   EMBL; CH471238; EAW79963.1; -; Genomic_DNA.
DR   EMBL; CH471238; EAW79964.1; -; Genomic_DNA.
DR   EMBL; BC136653; AAI36654.1; -; mRNA.
DR   EMBL; BC136655; AAI36656.1; -; mRNA.
DR   EMBL; BC142663; AAI42664.1; -; mRNA.
DR   EMBL; BC151221; AAI51222.1; -; mRNA.
DR   EMBL; BC152413; AAI52414.1; -; mRNA.
DR   EMBL; AY358942; AAQ89301.1; ALT_INIT; mRNA.
DR   IPI; IPI00006283; -.
DR   IPI; IPI00465168; -.
DR   IPI; IPI00641071; -.
DR   PIR; T46444; T46444.
DR   RefSeq; NP_004774.1; -.
DR   RefSeq; NP_057235.2; -.
DR   UniGene; Hs.291623; -.
DR   ProteinModelPortal; Q9UL54; -.
DR   SMR; Q9UL54; 12-320.
DR   IntAct; Q9UL54; 3.
DR   STRING; Q9UL54; -.
DR   PhosphoSite; Q9UL54; -.
DR   PRIDE; Q9UL54; -.
DR   Ensembl; ENST00000308893; ENSP00000310094; ENSG00000149930.
DR   GeneID; 9344; -.
DR   KEGG; hsa:9344; -.
DR   UCSC; uc002dva.1; human.
DR   UCSC; uc002dvc.1; human.
DR   UCSC; uc002dvd.1; human.
DR   CTD; 9344; -.
DR   GeneCards; GC16P029985; -.
DR   HGNC; HGNC:16835; TAOK2.
DR   HPA; HPA010650; -.
DR   MIM; 613199; gene.
DR   PharmGKB; PA134907964; -.
DR   HOVERGEN; HBG094024; -.
DR   InParanoid; Q9UL54; -.
DR   OMA; PYQPEME; -.
DR   PhylomeDB; Q9UL54; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; p38_mkk3_6pathway; p38 MAPK signaling pathway.
DR   NextBio; 34999; -.
DR   ArrayExpress; Q9UL54; -.
DR   Bgee; Q9UL54; -.
DR   CleanEx; HS_TAOK2; -.
DR   Genevestigator; Q9UL54; -.
DR   GermOnline; ENSG00000149930; Homo sapiens.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IDA:UniProtKB.
DR   GO; GO:0000186; P:activation of MAPKK activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptosis; NAS:UniProtKB.
DR   GO; GO:0016477; P:cell migration; NAS:UniProtKB.
DR   GO; GO:0048041; P:focal adhesion assembly; IDA:UniProtKB.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB.
DR   GO; GO:0006612; P:protein targeting to membrane; NAS:UniProtKB.
DR   GO; GO:0001558; P:regulation of cell growth; NAS:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IDA:UniProtKB.
DR   GO; GO:0006950; P:response to stress; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Coiled coil; Complete proteome;
KW   Cytoplasm; Cytoplasmic vesicle; Cytoskeleton; Kinase; Magnesium;
KW   Membrane; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Serine/threonine-protein kinase; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1   1235       Serine/threonine-protein kinase TAO2.
FT                                /FTId=PRO_0000086733.
FT   TRANSMEM    965    985       Helical; (Potential).
FT   TRANSMEM    987   1007       Helical; (Potential).
FT   TRANSMEM   1012   1032       Helical; (Potential).
FT   TRANSMEM   1043   1063       Helical; (Potential).
FT   DOMAIN       28    281       Protein kinase.
FT   NP_BIND      34     42       ATP (By similarity).
FT   COILED      486    547       Potential.
FT   COILED      574    601       Potential.
FT   COILED      681    713       Potential.
FT   COMPBIAS    330    336       Poly-Glu.
FT   COMPBIAS    347    370       Ser-rich.
FT   COMPBIAS    378    406       Glu-rich.
FT   COMPBIAS    791    907       Glu-rich.
FT   COMPBIAS    943   1060       Leu-rich.
FT   ACT_SITE    151    151       Proton acceptor (By similarity).
FT   BINDING      57     57       ATP (By similarity).
FT   MOD_RES       9      9       Phosphoserine.
FT   MOD_RES      43     43       Phosphotyrosine (By similarity).
FT   MOD_RES     181    181       Phosphoserine.
FT   MOD_RES     437    437       Phosphoserine.
FT   MOD_RES     449    449       Phosphoserine.
FT   MOD_RES     473    473       Phosphoserine.
FT   MOD_RES     486    486       Phosphoserine.
FT   MOD_RES     493    493       Phosphoserine.
FT   MOD_RES     777    777       Phosphoserine.
FT   MOD_RES     825    825       Phosphoserine.
FT   MOD_RES     827    827       Phosphoserine.
FT   VAR_SEQ       1    173       Missing (in isoform 3).
FT                                /FTId=VSP_015967.
FT   VAR_SEQ     174    218       SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT
FT                                CIEL -> MMGTSQGHVARKSRNWGLNPSRLSSIPLSSTPC
FT                                HLSPSSLSPFSV (in isoform 3).
FT                                /FTId=VSP_015968.
FT   VAR_SEQ     745   1049       VRAGQRPPGLPLPIPGALGPPNTGTPIEQQPCSPGQEAVLD
FT                                QRMLGEEEEAVGERRILGKEGATLEPKQQRILGEESGAPSP
FT                                SPQKHGSLVDEEVWGLPEEIEELRVPSLVPQERSIVGQEEA
FT                                GTWSLWGKEDESLLDEEFELGWVQGPALTPVPEEEEEEEEG
FT                                APIGTPRDPGDGCPSPDIPPEPPPTHLRPCPASQLPGLLSH
FT                                GLLAGLSFAVGSSSGLLPLLLLLLLPLLAAQGGGGLQAALL
FT                                ALEVGLVGLGASYLLLCTALHLPSSLFLLLAQGTALGAVLG
FT                                LSWRRGLMGVPLGLGAAW -> SKELQIKKQFQETCKIQTR
FT                                QYKALRAHLLETTPKAQHKSLLKRLKEEQTRKLAILAEQYD
FT                                QSISEMLSSQALRLDETQEAEFQALRQQLQQELELLNAYQS
FT                                KIKIRTESQHERELRELEQRVALRRALLEQRVEEELLALQT
FT                                GRSERIRSLLERQAREIEAFDAESMRLGFSSMALGGIPAEA
FT                                AAQGYPAPPPAPAWPSRPVPRSGAHWSHGPPPPGMPPPAWR
FT                                QPSLLAPPGPPNWLGPPTQSGTPRGGALLLLRNSPQPLRRA
FT                                ASGGSGSENVGPPAAAVPGPLSRSTSVASHILNGSSHFYS
FT                                (in isoform 2).
FT                                /FTId=VSP_015969.
FT   VAR_SEQ    1050   1235       Missing (in isoform 2).
FT                                /FTId=VSP_015970.
FT   MUTAGEN      57     57       K->A: Loss of kinase activity. In isoform
FT                                1, excluded from the nucleus. No effect
FT                                on microtubule-binding.
FT   MUTAGEN     169    169       D->A: Loss of kinase activity; No effect
FT                                on MAP3K7-mediated activation of NF-
FT                                kappa-B.
FT   MUTAGEN     919    919       D->N: No effect on kinase activity, nor
FT                                on JNK activation, but severe reduction
FT                                in nuclear localization and apoptotic
FT                                membrane blebbing.
FT   CONFLICT    189    189       M -> T (in Ref. 7; AAI51222/AAI42664).
FT   CONFLICT   1211   1211       R -> H (in Ref. 1; AAD45616).
SQ   SEQUENCE   1235 AA;  138251 MW;  211852E690934307 CRC64;
     MPAGGRAGSL KDPDVAELFF KDDPEKLFSD LREIGHGSFG AVYFARDVRN SEVVAIKKMS
     YSGKQSNEKW QDIIKEVRFL QKLRHPNTIQ YRGCYLREHT AWLVMEYCLG SASDLLEVHK
     KPLQEVEIAA VTHGALQGLA YLHSHNMIHR DVKAGNILLS EPGLVKLGDF GSASIMAPAN
     SFVGTPYWMA PEVILAMDEG QYDGKVDVWS LGITCIELAE RKPPLFNMNA MSALYHIAQN
     ESPVLQSGHW SEYFRNFVDS CLQKIPQDRP TSEVLLKHRF VLRERPPTVI MDLIQRTKDA
     VRELDNLQYR KMKKILFQEA PNGPGAEAPE EEEEAEPYMH RAGTLTSLES SHSVPSMSIS
     ASSQSSSVNS LADASDNEEE EEEEEEEEEE EEGPEAREMA MMQEGEHTVT SHSSIIHRLP
     GSDNLYDDPY QPEITPSPLQ PPAAPAPTST TSSARRRAYC RNRDHFATIR TASLVSRQIQ
     EHEQDSALRE QLSGYKRMRR QHQKQLLALE SRLRGEREEH SARLQRELEA QRAGFGAEAE
     KLARRHQAIG EKEARAAQAE ERKFQQHILG QQKKELAALL EAQKRTYKLR KEQLKEELQE
     NPSTPKREKA EWLLRQKEQL QQCQAEEEAG LLRRQRQYFE LQCRQYKRKM LLARHSLDQD
     LLREDLNKKQ TQKDLECALL LRQHEATREL ELRQLQAVQR TRAELTRLQH QTELGNQLEY
     NKRREQELRQ KHAAQVRQQP KSLKVRAGQR PPGLPLPIPG ALGPPNTGTP IEQQPCSPGQ
     EAVLDQRMLG EEEEAVGERR ILGKEGATLE PKQQRILGEE SGAPSPSPQK HGSLVDEEVW
     GLPEEIEELR VPSLVPQERS IVGQEEAGTW SLWGKEDESL LDEEFELGWV QGPALTPVPE
     EEEEEEEGAP IGTPRDPGDG CPSPDIPPEP PPTHLRPCPA SQLPGLLSHG LLAGLSFAVG
     SSSGLLPLLL LLLLPLLAAQ GGGGLQAALL ALEVGLVGLG ASYLLLCTAL HLPSSLFLLL
     AQGTALGAVL GLSWRRGLMG VPLGLGAAWL LAWPGLALPL VAMAAGGRWV RQQGPRVRRG
     ISRLWLRVLL RLSPMAFRAL QGCGAVGDRG LFALYPKTNK DGFRSRLPVP GPRRRNPRTT
     QHPLALLARV WVLCKGWNWR LARASQGLAS HLPPWAIHTL ASWGLLRGER PTRIPRLLPR
     SQRQLGPPAS RQPLPGTLAG RRSRTRQSRA LPPWR
//
